Bristol Myers Squibb to Acquire Turning Point Therapeutics, a Leading Precision Oncology Company

Go back to Bristol Myers Squibb to Acquire Turning Point Therapeutics, a Leading Precision Oncology Company
Bristol-Myers Squibb (NYSE: BMY) Delayed: 59.59 --0 (-0%)
Previous Close $59.59    52 Week High $77.12 
Open $59.59    52 Week Low $49.03 
Day High $59.59    P/E 38.69 
Day Low $59.59    EPS $1.54 
Volume 2,731       

TORREYPINES THERA (NASDAQ: TPTX) Delayed: 76.01 --0 (-0%)
Previous Close $76.01    52 Week High $0.69 
Open $0.10    52 Week Low $0.07 
Day High $76.01    P/E N/A 
Day Low $76.01    EPS $-0.90 
Volume 11,307